Combining shallow and deep neural networks on pseudo-color enhanced images for digital breast tomosynthesis lesion classification.
[INTRODUCTION] The classification of lesion types in Digital Breast Tomosynthesis (DBT) images is crucial for the early diagnosis of breast cancer.
APA
Yang Z, Liu Y, et al. (2025). Combining shallow and deep neural networks on pseudo-color enhanced images for digital breast tomosynthesis lesion classification.. Frontiers in digital health, 7, 1705044. https://doi.org/10.3389/fdgth.2025.1705044
MLA
Yang Z, et al.. "Combining shallow and deep neural networks on pseudo-color enhanced images for digital breast tomosynthesis lesion classification.." Frontiers in digital health, vol. 7, 2025, pp. 1705044.
PMID
41586202
Abstract
[INTRODUCTION] The classification of lesion types in Digital Breast Tomosynthesis (DBT) images is crucial for the early diagnosis of breast cancer. However, the task remains challenging due to the complexity of breast tissue and the subtle nature of lesions. To alleviate radiologists' workload, computer-aided diagnosis (CAD) systems have been developed. The breast lesion regions vary in size and complexity, which leads to performance degradation.
[METHODS] To tackle this problem, we propose a novel DBT Dual-Net architecture comprising two complementary neural network branches that extract both low-level and high-level features. By fusing different-level feature representations, the model can better capture subtle structure. Furthermore, we introduced a pseudo-color enhancement procedure to improve the visibility of lesions on DBT. Moreover, most existing DBT classification studies rely on two-dimensional (2D) slice-level analysis, neglecting the rich three-dimensional (3D) spatial context within DBT volumes. To address this limitation, we used majority voting for image-level classification from predictions across slices.
[RESULTS] We evaluated our method on a public DBT dataset and compared its performance with several existing classification approaches. The results showed that our method outperforms baseline models.
[DISCUSSION] The use of pseudo-color enhancement, extracting high and low-level features and inter-slice majority voting proposed method is effective for lesion classification in DBT. The code is available at https://github.com/xiaoerlaigeid/DBT-Dual-Net.
[METHODS] To tackle this problem, we propose a novel DBT Dual-Net architecture comprising two complementary neural network branches that extract both low-level and high-level features. By fusing different-level feature representations, the model can better capture subtle structure. Furthermore, we introduced a pseudo-color enhancement procedure to improve the visibility of lesions on DBT. Moreover, most existing DBT classification studies rely on two-dimensional (2D) slice-level analysis, neglecting the rich three-dimensional (3D) spatial context within DBT volumes. To address this limitation, we used majority voting for image-level classification from predictions across slices.
[RESULTS] We evaluated our method on a public DBT dataset and compared its performance with several existing classification approaches. The results showed that our method outperforms baseline models.
[DISCUSSION] The use of pseudo-color enhancement, extracting high and low-level features and inter-slice majority voting proposed method is effective for lesion classification in DBT. The code is available at https://github.com/xiaoerlaigeid/DBT-Dual-Net.
같은 제1저자의 인용 많은 논문 (5)
- Analysis of the effect of neuroendoscopy-assisted microscopy in the treatment of Large (Koos grade IV) vestibular schwannoma.
- Novel Resorcinol Dibenzyl Ether-Based PD-L1 Inhibitors Modulate Lipid Metabolism for Enhanced Tumor Immunotherapy.
- Early diagnosis of colorectal cancer using Cerenkov luminescence endoscopy: a pilot trial involving humans for the first time.
- The diagnostic and therapeutic challenges of pulmonary epithelioid trophoblastic tumor: A case report and literature review.
- Yuxingcao formula suppresses acute erythroleukemia through inhibition of AKT1 and FLI1.